lidocaine has been researched along with trifluoperazine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Chiang, GH; Unger, SH | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Carrupt, PA; Martel, S; Ottaviani, G | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Papadimituiou, JM; Sforcina, D | 1 |
| Ohishi, K; Suzuki, T; Uchida, MK | 1 |
| Hait, WN; Kennedy, KA; Lazo, JS | 1 |
| Enyeart, JJ; Hinkle, PM; Phillips, WJ | 1 |
| Bentwich, Z; Bibi, H; Eliraz, A; Fink, A; Tabachnik, E | 1 |
| Karnovsky, MJ; Ryan, GB; Unanue, ER | 1 |
| Goodenough, UW | 1 |
| Choi, DS; Han, BG; Hur, GH; Kim, YB; Lee, YS; Shin, S; Sok, DE | 1 |
| Amir, A; Barness, I; Chapman, S; Fishbeine, E; Kadar, T; Liani, H; Meshulam, Y; Sahar, R | 1 |
| Chow, JC; Christ, WJ; Daun, JM; Gusovsky, F; Rose, JR; Yang, H | 1 |
1 review(s) available for lidocaine and trifluoperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for lidocaine and trifluoperazine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
Topics: Amines; Animals; Buffers; Chromatography, High Pressure Liquid; Histamine Release; Lipid Metabolism; Octanols; Protein Binding; Rats; Serum Albumin, Bovine; Sodium-Potassium-Exchanging ATPase; Solubility; Structure-Activity Relationship | 1981 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The effects of drugs on monocytic fusion in vivo.
Topics: Adenosine Triphosphatases; Animals; Calcium; Cell Fusion; Cell Membrane; Cortisone; Cyclic AMP; Diphenhydramine; Edetic Acid; Glucagon; Insulin; Isoproterenol; Lidocaine; Lysosomes; Male; Mice; Mice, Inbred C57BL; Monocytes; Ouabain; Pyrilamine; Tetracaine; Trifluoperazine; Verapamil | 1975 |
Relation between inhibition of calmodulin and mediator release from rat mast cells.
Topics: Animals; Calcium; Calmodulin; Chlorpromazine; Histamine Release; Lidocaine; Liposomes; Male; Mast Cells; Rats; Rats, Inbred Strains; Serotonin; Structure-Activity Relationship; Sulfonamides; Trifluoperazine | 1985 |
Chemical modulation of bleomycin induced toxicity.
Topics: Animals; Antineoplastic Agents; Bleomycin; Calmodulin; DNA Damage; Drug Synergism; In Vitro Techniques; Leukemia L1210; Lidocaine; Pimozide; Trifluoperazine | 1986 |
Pituitary thyrotropin-releasing hormone receptors: local anesthetic effects on binding and responses.
Topics: Anesthetics, Local; Animals; Benzocaine; Chlordiazepoxide; Chlorpromazine; Dibucaine; Hydrogen-Ion Concentration; Imipramine; Lidocaine; Pituitary Gland; Procaine; Prolactin; Propranolol; Rats; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Tetracaine; Thyrotropin-Releasing Hormone; Trifluoperazine; Verapamil | 1989 |
Leukotrienes (LTC4, LTD4) confer glass non-adherence on leukocytes of asthmatic individuals. Dependency on cyclooxygenase products and calcium ion.
Topics: Asthma; Calcium; Cell Adhesion; Child; Cyclooxygenase Inhibitors; Dinoprostone; Glass; Humans; Indomethacin; Lanthanum; Leukocyte Adherence Inhibition Test; Leukocytes; Lidocaine; Nifedipine; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; SRS-A; Trifluoperazine | 1985 |
Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers.
Topics: Animals; Binding Sites, Antibody; Cell Membrane; Chlorpromazine; Concanavalin A; Dibucaine; Humans; Immunoglobulins; Lidocaine; Lymphocytes; Mice; Neutrophils; Trifluoperazine | 1974 |
Tipping of flagellar agglutinins by gametes of Chlamydomonas reinhardtii.
Topics: 1-Methyl-3-isobutylxanthine; Agglutinins; Alkaloids; Animals; Bucladesine; Cadmium; Cell Adhesion; Cell Movement; Chlamydomonas reinhardtii; Colchicine; Diltiazem; Flagella; Germ Cells; Isoquinolines; Lanthanum; Lidocaine; Models, Biological; Plant Proteins; Protozoan Proteins; Reproduction; Staurosporine; Trifluoperazine | 1993 |
Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide.
Topics: Adjuvants, Anesthesia; Administration, Topical; Anesthetics, Local; Animals; Burns, Chemical; Calmodulin; Dopamine Antagonists; Dosage Forms; Female; Lidocaine; Mice; Mice, Hairless; Mustard Gas; Pentamidine; Pentobarbital; Skin; Thioridazine; Trifluoperazine | 1996 |
Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model.
Topics: Administration, Topical; Anesthetics, Local; Animals; Blister; Calmodulin; Dermatologic Agents; Disease Models, Animal; Dopamine Antagonists; Female; Injections, Intradermal; Lidocaine; Mustard Gas; Procaine; Swine; Thioridazine; Trifluoperazine | 2000 |
Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531.
Topics: Adolescent; Adult; Cell Line; Chlorpromazine; Female; Fluphenazine; Humans; In Vitro Techniques; Interleukin-6; Leukocytes, Mononuclear; Lidocaine; Lipid A; Lipopolysaccharides; Male; Middle Aged; Rhodobacter sphaeroides; Trifluoperazine | 2000 |